Aristides Capital’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History

Aristides Capital’s Portfolio CSLT Stock Details CSLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-52,008	Closed	-$69K	–	278
2019 Q4	$69K	Buy	+52,008	New	+$72.6K	0.05%	211

Other funds holding CSLT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aristides Capital's CSLT Position: Q1 2020 in Review

Aristides Capital sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q1 2020, closing a stake of 52,008 shares — an estimated $69K sold.

Aristides Capital first reported a position in CSLT in Q4 2019 and held it in 1 quarter. The position peaked at $69K in Q4 2019. 86 funds tracked by Wall St. Rank hold CSLT as of Q1 2020.

Aristides Capital reported no remaining CASTLIGHT HEALTH, INC. position as of Q1 2020 after selling out during the quarter.
Aristides Capital sold 52,008 CASTLIGHT HEALTH, INC. shares in Q1 2020, an estimated $69K.
Aristides Capital first reported a position in CASTLIGHT HEALTH, INC. in Q4 2019 and held it in 1 quarter.
Aristides Capital's CASTLIGHT HEALTH, INC. position peaked at $69K in Q4 2019.
86 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q1 2020.

Based on Aristides Capital's 13F filing for Q1 2020, filed 15 May 2020.